Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents
US6784198B1 · kind B1 · utility
23Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 18, 2002 |
| Grant date | Aug 31, 2004 |
| Priority date | — |
| Expiry date | Jul 18, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D277/46
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
2-amino-1,3-thiazole derivatives represented by formula (I) or (II): where R, R1, R2 and R3 are defined herein, or pharmaceutically acceptable salts thereof are useful as, for example, the treatment of cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases or neurodegenerative diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.